Table of Contents
Chapter 1. Global Disease Demographics for Diabetes Type 1 and Type 2
1.1. Market Outlook
1.1.1. Diabetes type 1
1.1.2. Diabetes type 2
Chapter 2. Patient Demographics: Global Disease Demographics for Diabetes Type 1 and Type 2
2.1. Total Population
2.2. People with Diabetes
2.3. People with Undiagnosed Diabetes
2.4. Deaths Attributable to Diabetes
Chapter 3. Treatment Options: Global Disease Demographics for Diabetes Type 1 and Type 2
3.1. Type 1 Diabetes
3.1.1. Insulin
3.1.2. Diet
3.1.3. Blood glucose monitoring
3.2. Type 2 Diabetes
3.2.1. Oral Medications
3.2.2. Diet
3.2.3. Exercise
3.2.4. Blood glucose monitoring
3.2.5. Insulin
Chapter 4. Quality of Life: Global Disease Demographics for Diabetes Type 1 and Type 2
4.1. Disability-adjusted life years (DALYs)
Chapter 5. Comorbidity Analysis: Global Disease Demographics for Diabetes Type 1 and Type 2
5.1. Diabetic Foot Ulcers
5.2. Cardiovascular Disease (CVD)
5.3. Diabetic Retinopathy
5.4. Diabetic Neuropathy
5.5. Diabetic Nephropathy
Chapter 6. Reimbursement Differences: Global Disease Demographics for Diabetes Type 1 and Type 2
6.1. Coverage for Medicare and Medicaid
6.1.1. Type 1 Diabetes
6.1.2. Type 2 Diabetes
Chapter 7. Regional Outlook: Global Disease Demographics for Diabetes Type 1 and Type 2
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.2. Europe
7.2.1. UK
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Denmark
7.2.7. Sweden
7.2.8. Norway
7.3. Asia Pacific
7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. Australia
7.3.5. Thailand
7.3.6. South Korea
7.4. Latin America
7.4.1. Brazil
7.4.2. Mexico
7.4.3. Argentina
7.5. Middle East and Africa
7.5.1. South Africa
7.5.2. Saudi Arabia
7.5.3. UAE
7.5.4. Kuwait